EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Profile of darunavir in the treatment of HIV-infected pediatric and adolescent patients

Joanna Dobroszycki, Jacobo Abadi, Andrew A Wiznia, Michael G Rosenberg

Adolescent Health, Medicine and Therapeutics · 2011

DOI: 10.2147/ahmt.s11177 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Adolescent Health, Medicine and Therapeutics, 2011. Verfasst von Joanna Dobroszycki und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Division of Infectious Diseases, Jacobi Medical Center, Bronx, NY, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The introduction of protease inhibitors (PI) containing antiretroviral regimens in the treatment of HIV infection in infants, children, and adolescents has dramatically decreased morbidity and mortality. Darunavir, the latest PI to be FDA approved for pediatric patients older than 6 years and currently the preferred PI for use in adult patients, was added as an alternative PI for use in children based on a combination of data from both adult and pediatric trials. This review of darunavir in the treatment of HIV-infected children and adolescents looks at the major published clinical trials findings, pharmacokinetic and resistance studies, and preliminary data on use in younger children.

Schlagwörter

Stichwörter der Autor:innen

HIVdarunavirprotease inhibitor

Autor:innen und Institutionen

  • Department of Pediatrics, Division of Infectious Diseases, Jacobi Medical Center, Bronx, NY, USA.

Zitieren

APA

Dobroszycki, J., Abadi, J., Wiznia, A. A., & Rosenberg, M. G. (2011). Profile of darunavir in the treatment of HIV-infected pediatric and adolescent patients. Adolescent Health, Medicine and Therapeutics. https://doi.org/10.2147/ahmt.s11177

Vancouver

Dobroszycki J, Abadi J, Wiznia AA, Rosenberg MG. Profile of darunavir in the treatment of HIV-infected pediatric and adolescent patients. Adolescent Health, Medicine and Therapeutics. 2011. doi:10.2147/ahmt.s11177

BibTeX
@article{Dobroszycki2011,
  author = {Dobroszycki, Joanna and Abadi, Jacobo and Wiznia, Andrew A and Rosenberg, Michael G},
  title = {Profile of darunavir in the treatment of HIV-infected pediatric and adolescent patients},
  journal = {Adolescent Health, Medicine and Therapeutics},
  year = {2011},
  doi = {10.2147/ahmt.s11177}
}
Kostenlos starten →